Structural and molecular basis of interaction of HCV non-structural protein 5A with human casein kinase 1α and PKR

BMC Structural Biology

Volumn 12, Issue , 2012, Pages

  Sudha, Govindarajan ^a   Yamunadevi, Subburaj ^a,b   Tyagi, Nidhi ^a,c   Das, Saumitra ^a   Srinivasan, Narayanaswamy ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

Author keywords

Casein kinase 1 ; Hepatitis C virus; Interferon therapy; Kinase substrate complex; Non structural protein 5A; Protein kinase R

Indexed keywords

CASEIN KINASE IALPHA; NONSTRUCTURAL PROTEIN 5A; PROTEIN KINASE R; PROTEIN P53;

ARTICLE; CRYSTAL STRUCTURE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TRANSACTIVATION;

ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; CASEIN KINASE IALPHA; CRYSTALLOGRAPHY, X-RAY; EIF-2 KINASE; EVOLUTION, MOLECULAR; GENOTYPE; HEPACIVIRUS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHOSERINE; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; STRUCTURAL HOMOLOGY, PROTEIN; SUBSTRATE SPECIFICITY; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 84868668512     PISSN: None     EISSN: 14726807     Source Type: Journal    
DOI: 10.1186/1472-6807-12-28     Document Type: Article

References (61)

1. Course and outcome of hepatitis C. Hoofnagle JH, Hepatology 2002 36 5 Suppl 1 21 S29 12407573
2. Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication? Huang Y, Staschke K, De Francesco R, Tan SL, Virology 2007 364 1 1 9 10.1016/j.virol.2007.01.042 17400273
3. Viral determinants of resistance to treatment in patients with hepatitis C. Wohnsland A, Hofmann WP, Sarrazin C, Clin Microbiol Rev 2007 20 1 23 38 10.1128/CMR.00010-06 17223621
4. Replication of hepatitis C virus. Moradpour D, Penin F, Rice CM, Nat Rev Microbiol 2007 5 6 453 463 10.1038/nrmicro1645 17487147
5. Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A. Penin F, Brass V, Appel N, Ramboarina S, Montserret R, Ficheux D, Blum HE, Bartenschlager R, Moradpour D, J Biol Chem 2004 279 39 40835 40843 10.1074/jbc.M404761200 15247283
6. Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Tellinghuisen TL, Marcotrigiano J, Rice CM, Nature 2005 435 7040 374 379 10.1038/nature03580 15902263
7. Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus. Love RA, Brodsky O, Hickey MJ, Wells PA, Cronin CN, J Virol 2009 83 9 4395 4403 10.1128/JVI.02352-08 19244328
8. Natively unfolded proteins. Fink AL, Curr Opin Struct Biol 2005 15 1 35 41 10.1016/j.sbi.2005.01.002 15718131
9. Domain 3 of non-structural protein 5A from hepatitis C virus is natively unfolded. Hanoulle X, Verdegem D, Badillo A, Wieruszeski JM, Penin F, Lippens G, Biochem Biophys Res Commun 2009 381 4 634 638 10.1016/j.bbrc.2009.02.108 19249289
10. Domain 2 of nonstructural protein 5A (NS5A) of hepatitis C virus is natively unfolded. Liang Y, Ye H, Kang CB, Yoon HS, Biochemistry 2007 46 41 11550 11558 10.1021/bi700776e 17880107
11. Domain 3 of NS5A Protein from the Hepatitis C Virus Has Intrinsic {alpha}-Helical Propensity and Is a Substrate of Cyclophilin A. Verdegem D, Badillo A, Wieruszeski JM, Landrieu I, Leroy A, Bartenschlager R, Penin F, Lippens G, Hanoulle X, J Biol Chem 2011 286 23 20441 20454 10.1074/jbc.M110. 182436 21489988
12. Hepatitis C virus NS5A: tales of a promiscuous protein. Macdonald A, Harris M, J Gen Virol 2004 85 Pt 9 2485 2502 15302943
13. Hepatitis C virus NS5A is a direct substrate of casein kinase 1-α, a cellular kinase identified by inhibitor affinity chromatography using specific NS5A hyperphosphorylation Inhibitors. Quintavalle M, Sambucini S, Summa V, Orsatti L, Talamo F, Francesco RD, Neddermann P, J Biol Chem 2006 282 5536 5544 10.1074/jbc.M610486200 17166835
14. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Gale M Jr, Blakely CM, Kwieciszewski B, Tan SL, Dossett M, Tang NM, Korth MJ, Polyak SJ, Gretch DR, Katze MG, Mol Cell Biol 1998 18 9 5208 5218 9710605
15. The NS5A/NS5 proteins of viruses from three genera of the family flaviviridae are phosphorylated by associated serine/threonine kinases. Reed KE, Gorbalenya AE, Rice CM, J Virol 1998 72 7 6199 6206 9621090
16. A central role for CK1 in catalyzing phosphorylation of the p53 transactivation domain at serine 20 after HHV-6B viral infection. MacLaine NJ, Oster B, Bundgaard B, Fraser JA, Buckner C, Lazo PA, Meek DW, Hollsberg P, Hupp TR, J Biol Chem 2008 283 42 28563 28573 10.1074/jbc.M804433200 18669630
17. The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Knippschild U, Gocht A, Wolff S, Huber N, Lohler J, Stoter M, Cell Signal 2005 17 6 675 689 10.1016/j.cellsig.2004.12.011 15722192
18. Crystal structure of casein kinase-1, a phosphate-directed protein kinase. Xu RM, Carmel G, Sweet RM, Kuret J, Cheng X, EMBO J 1995 14 5 1015 1023 7889932
19. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Knighton DR, Zheng JH, Ten Eyck LF, Xuong NH, Taylor SS, Sowadski JM, Science 1991 253 5018 414 420 10.1126/science.1862343 1862343
20. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Brown NR, Noble ME, Endicott JA, Johnson LN, Nat Cell Biol 1999 1 7 438 443 10.1038/15674 10559988
21. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP, Science 1996 274 5289 948 953 10.1126/science.274.5289. 948 8875929
22. Higher-order substrate recognition of eIF2alpha by the RNA-dependent protein kinase PKR. Dar AC, Dever TE, Sicheri F, Cell 2005 122 6 887 900 10.1016/j.cell.2005.06.044 16179258
23. Boceprevir for previously treated chronic HCV genotype 1 infection. Bacon BR, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, Poordad F, Goodman ZD, Sings HL, Boparai N, et al. N Engl J Med 2011 364 13 1207 1217 10.1056/NEJMoa1009482 21449784
24. Boceprevir for untreated chronic HCV genotype 1 infection. Poordad F, McCone J Jr, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, Reddy KR, Goodman ZD, Boparai N, et al. N Engl J Med 2011 364 13 1195 1206 10.1056/NEJMoa1010494 21449783
25. Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir. Swiss Association for the Study of the Liver, Swiss Med Wkly 2012 142 13516 22367957
26. Development of novel therapies for hepatitis C. Lemon SM, McKeating JA, Pietschmann T, Frick DN, Glenn JS, Tellinghuisen TL, Symons J, Furman PA, Antiviral Res 2010 86 1 79 92 10.1016/j.antiviral.2010.02.003 20417376
27. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, et al. N Engl J Med 2002 347 13 975 982 10.1056/NEJMoa020047 12324553
28. Enhancing the response to interferon-alpha. Begemann F, Jablonowski H, J Clin Virol 1999 13 1-2 1 7 10475732
29. Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells. Noguchi T, Satoh S, Noshi T, Hatada E, Fukuda R, Kawai A, Ikeda S, Hijikata M, Shimotohno K, Microbiol Immunol 2001 45 12 829 840 11838900
30. Variability of the Nonstructural 5A Protein of Hepatitis C Virus Type 3a Isolates and Relation to Interferon Sensitivity. Castelain S, Khorsi H, Roussel J, François C, Jaillon O, Capron D, Penin F, Wychowski C, Meurs E, Duverlie G, J Infect Dis 2002 185 573 583 10.1086/339051 11865413
31. An evolutionary trace method defines binding surfaces common to protein families. Lichtarge O, Bourne HR, Cohen FE, J Mol Biol 1996 257 2 342 358 10.1006/jmbi.1996.0167 8609628
32. Accurate and scalable identification of functional sites by evolutionary tracing. Lichtarge O, Yao H, Kristensen DM, Madabushi S, Mihalek I, J Struct Funct Genomics 2003 4 2-3 159 166 14649300
33. DeLano WL, The PyMOL Molecular Graphics System San Carlos, CA, USA: DeLano Scientific 2002
34. Substrate and docking interactions in serine/threonine protein kinases. Goldsmith EJ, Akella R, Min X, Zhou T, Humphreys JM, Chem Rev 2007 107 11 5065 5081 10.1021/cr068221w 17949044
35. A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Songyang Z, Lu KP, Kwon YT, Tsai LH, Filhol O, Cochet C, Brickey DA, Soderling TR, Bartleson C, Graves DJ, et al. Mol Cell Biol 1996 16 11 6486 6493 8887677
36. DaliLite workbench for protein structure comparison. Holm L, Park J, Bioinformatics 2000 16 6 566 567 10.1093/bioinformatics/16.6.566 10980157
37. JOY: protein sequence-structure representation and analysis. Mizuguchi K, Deane CM, Blundell TL, Johnson MS, Overington JP, Bioinformatics 1998 14 7 617 623 10.1093/bioinformatics/14.7.617 9730927
38. PIC: Protein Interactions Calculator. Tina KG, Bhadra R, Srinivasan N, Nucleic Acids Res 2007 35 Web Server issue 473 W476 17584791
39. The evolutionary conundrum of pathogen mimicry. Elde NC, Malik HS, Nat Rev Microbiol 2009 7 11 787 797 10.1038/nrmicro2222 19806153
40. The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism. Tsai YH, Kuang WF, Lu TY, Kao JH, Lai MY, Liu CJ, Chen PJ, Hwang LH, J Hepatol 2008 49 6 899 907 10.1016/j.jhep.2008.06. 030 18842320
41. Genetic diversity and evolution of hepatitis C virus-15 years on. Simmonds P, J Gen Virol 2004 85 Pt 11 3173 3188 15483230
42. Interference with p53 functions in human viral infections, a target for novel antiviral strategies? Lazo PA, Santos CR, Rev Med Virol 2011 21 5 285 300
43. Modes of p53 regulation. Kruse JP, Gu W, Cell 2009 137 4 609 622 10.1016/j.cell.2009.04.050 19450511
44. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY, et al. Oncogene 2002 21 31 4801 4811 10.1038/sj.onc.1205589 12101418
45. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. Majumder M, Ghosh AK, Steele R, Ray R, Ray RB, J Virol 2001 75 3 1401 1407 10.1128/JVI.75.3.1401-1407.2001 11152513
46. Hepatitis C virus diversity and evolution in the full open-reading frame during antiviral therapy. Cannon NA, Donlin MJ, Fan X, Aurora R, Tavis JE, PLoS One 2008 3 5 2123 10.1371/journal.pone.0002123 18463735
47. Basic local alignment search tool. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ, J Mol Biol 1990 215 3 403 410 2231712
48. Knowledge based modelling of homologous proteins, Part I: Three-dimensional frameworks derived from the simultaneous superposition of multiple structures. Sutcliffe MJ, Haneef I, Carney D, Blundell TL, Protein Eng 1987 1 5 377 384 10.1093/protein/1.5.377 3508286
49. Knowledge based modelling of homologous proteins, Part II: Rules for the conformations of substituted sidechains. Sutcliffe MJ, Hayes FR, Blundell TL, Protein Eng 1987 1 5 385 392 10.1093/protein/1.5.385 3508287
50. An evaluation of the performance of an automated procedure for comparative modelling of protein tertiary structure. Srinivasan N, Blundell TL, Protein Eng 1993 6 5 501 512 10.1093/protein/6.5.501 8415577
51. 18th Sir Hans Krebs Lecture Knowledge-based protein modelling and design. Blundell T, Carney D, Gardner S, Hayes F, Howlin B, Hubbard T, Overington J, Singh DA, Sibanda BL, Sutcliffe M, Eur J Biochem 1988 172 513 520 10.1111/j.1432-1033.1988.tb13917.x 3280310
52. An all atom force field for simulations of proteins and nucleic Acids. Weiner SJ, Kollman PA, J Comput Chem 1986 7 230 252 10.1002/jcc.540070216
53. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Thompson JD, Higgins DG, Gibson TJ, Nucleic Acids Res 1994 22 22 4673 4680 10.1093/nar/22.22.4673 7984417
54. A new, structurally nonredundant, diverse data set of protein-protein interfaces and its implications. Keskin O, Tsai CJ, Wolfson H, Nussinov R, Protein Sci 2004 13 4 1043 1055 10.1110/ps.03484604 15044734
55. Structural invariants in protein folding. Chothia C, Nature 1975 254 5498 304 308 10.1038/254304a0 1118010
56. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Katoh K, Misawa K, Kuma K, Miyata T, Nucleic Acids Res 2002 30 14 3059 3066 10.1093/nar/gkf436 12136088
57. T-Coffee: A novel method for fast and accurate multiple sequence alignment. Notredame C, Higgins DG, Heringa J, J Mol Biol 2000 302 1 205 217 10.1006/jmbi.2000.4042 10964570
58. ProbCons: Probabilistic consistency-based multiple sequence alignment. Do CB, Mahabhashyam MS, Brudno M, Batzoglou S, Genome Res 2005 15 2 330 340 10.1101/gr.2821705 15687296
59. Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ, Bioinformatics 2009 25 9 1189 1191 10.1093/bioinformatics/btp033 19151095
60. euHCVdb: the European hepatitis C virus database. Combet C, Garnier N, Charavay C, Grando D, Crisan D, Lopez J, Dehne-Garcia A, Geourjon C, Bettler E, Hulo C, et al. Nucleic Acids Res 2007 35 Database issue 363 D366 17142229
61. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Li W, Godzik A, Bioinformatics 2006 22 13 1658 1659 10.1093/bioinformatics/btl158 16731699